Immunocore claims first-ever FDA approval for TCR cancer therapy
pharmaphorum
JANUARY 26, 2022
“Every year in the US, hundreds of people are diagnosed with metastatic uveal melanoma who, until now, had no approved treatment options,” said Immunocore chief executive Bahija Jallal.
Let's personalize your content